- Home
- CPRT vs HUMAW Comparison
CPRT vs HUMAW Comparison
Compare CPRT & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRT
- HUMAW
- Stock Information
- Founded
- CPRT 1982
- HUMAW 2004
- Country
- CPRT United States
- HUMAW United States
- Employees
- CPRT N/A
- HUMAW 220
- Industry
- CPRT Other Specialty Stores
- HUMAW Biotechnology: Pharmaceutical Preparations
- Sector
- CPRT Consumer Discretionary
- HUMAW Health Care
- Exchange
- CPRT Nasdaq
- HUMAW Nasdaq
- Market Cap
- CPRT N/A
- HUMAW N/A
- IPO Year
- CPRT 1994
- HUMAW N/A
- Fundamental
- Price
- CPRT $50.80
- HUMAW $0.54
- Analyst Decision
- CPRT Buy
- HUMAW
- Analyst Count
- CPRT 2
- HUMAW 0
- Target Price
- CPRT $55.50
- HUMAW N/A
- AVG Volume (30 Days)
- CPRT 6.7M
- HUMAW 14.2K
- Earning Date
- CPRT 05-22-2025
- HUMAW 03-21-2025
- Dividend Yield
- CPRT N/A
- HUMAW N/A
- EPS Growth
- CPRT 5.62
- HUMAW N/A
- EPS
- CPRT 1.51
- HUMAW N/A
- Revenue
- CPRT $4,590,860,000.00
- HUMAW N/A
- Revenue This Year
- CPRT $13.53
- HUMAW N/A
- Revenue Next Year
- CPRT $9.23
- HUMAW N/A
- P/E Ratio
- CPRT $33.64
- HUMAW N/A
- Revenue Growth
- CPRT 10.21
- HUMAW N/A
- 52 Week Low
- CPRT $48.05
- HUMAW $1.18
- 52 Week High
- CPRT $64.38
- HUMAW $1.34
- Technical
- Relative Strength Index (RSI)
- CPRT 21.94
- HUMAW N/A
- Support Level
- CPRT $61.66
- HUMAW N/A
- Resistance Level
- CPRT $63.85
- HUMAW N/A
- Average True Range (ATR)
- CPRT 1.33
- HUMAW 0.00
- MACD
- CPRT -1.38
- HUMAW 0.00
- Stochastic Oscillator
- CPRT 4.26
- HUMAW 0.00
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.